Literature DB >> 2764721

A pneumotoxin, O,O,S-trimethyl phosphorothioate, induces hemorheological alteration in rats.

M L Bezençon1, S K Durham, J Roux, E M Grandjean, T Imamura.   

Abstract

O,O,S-trimethyl phosphorothioate (OOS-TMP), an impurity present in widely used organophosphorus insecticides, has been shown to induce lung injury after oral administration. To date, very little is known about the hemorheological changes which may occur during the inflammation of lung caused by OOS-TMP. The present study has demonstrated that oral administration of OOS-TMP (10 mg/kg, 20 mg/kg) to rats produced an increase in whole blood apparent viscosity at 24, 48 and 72 h following the treatment in rats. Concomitantly, the plasma fibrinogen level and red blood cell (RBC) aggregation were increased at 24 and 48 h. There was no change in RBC filterability. Thus, OOS-TMP, a pneumotoxin, was capable of causing a systemic hemorheological alteration, probably via increase in fibrinogen content, an acute-phase protein, in rats.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2764721     DOI: 10.1007/BF00278647

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  19 in total

1.  Role of the non-Newtonian behavior of blood in hemodynamics.

Authors:  R H HAYNES; A C BURTON
Journal:  Am J Physiol       Date:  1959-11

2.  [Rapid physiological coagulation method in determination of fibrinogen].

Authors:  A CLAUSS
Journal:  Acta Haematol       Date:  1957-04       Impact factor: 2.195

3.  A counter-rotating "rheoscope chamber" for the study of the microrheology of blood cell aggregation by microscopic observation and microphotometry.

Authors:  H Schmid-Schönbein; J von Gosen; L Heinich; H J Klose; E Volger
Journal:  Microvasc Res       Date:  1973-11       Impact factor: 3.514

4.  Blood viscosity in experimental acute renal failure.

Authors:  T W Kurtz; J M Slavicek; C H Hsu
Journal:  Nephron       Date:  1982       Impact factor: 2.847

5.  Impaired red cell deformability in peripheral vascular disease.

Authors:  H L Reid; J A Dormandy; A J Barnes; P J Lock; T L Dormandy
Journal:  Lancet       Date:  1976-03-27       Impact factor: 79.321

6.  Alterations of alveolar macrophage function and level of bronchopulmonary protease inhibitors in O,O,S-trimethyl phosphorothioate-induced lung injury.

Authors:  T Imamura; I K Thomas
Journal:  Toxicology       Date:  1985-10       Impact factor: 4.221

7.  Malathion and phenthoate carboxylesterase activities in pulmonary alveolar macrophages as indicators of lung injury.

Authors:  T Imamura; N L Schiller; T R Fukuto
Journal:  Toxicol Appl Pharmacol       Date:  1983-08       Impact factor: 4.219

8.  Sequential and dose-dependent alterations in rat bronchiolar epithelium during O,O,S-trimethyl phosphorothioate induced delayed toxicity.

Authors:  J Gandy; T R Fukuto; T Imamura
Journal:  J Pathol       Date:  1984-06       Impact factor: 7.996

9.  A phosphorothionate isomer protects against the pneumotoxicity caused by O,O,S-trimethyl phosphorothioate.

Authors:  J Gandy; T Imamura
Journal:  Toxicol Appl Pharmacol       Date:  1987-03-15       Impact factor: 4.219

10.  Morphological alterations of rat lung bronchiolar epithelium produced by various trialkyl phosphorothioates.

Authors:  J Gandy; F A Ali; L Hasegawa; T Imamura
Journal:  Toxicology       Date:  1984-07       Impact factor: 4.221

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.